Seroprevalence of SARS-CoV-2–specific antibodies in cancer outpatients in Madrid (Spain): A single center, prospective, cohort study and a review of available data

BACKGROUND: Coronavirus disease in 2019 (COVID-19) caused by Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) has emerged as a global pandemic. Published data suggests that patients with a history of or active malignancy are at increased risk of infection and developing COVID-19 related...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Cancer Treat Rev
Main Authors: Cabezón-Gutiérrez, Luis, Custodio-Cabello, Sara, Palka-Kotlowska, Magda, Oliveros-Acebes, Eduardo, García-Navarro, María José, Khosravi-Shahi, Parham
Formato: Artigo
Idioma:Inglês
Publicado em: Elsevier Ltd. 2020
Assuntos:
Hot Topic
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7462449/
https://ncbi.nlm.nih.gov/pubmed/32947121
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ctrv.2020.102102
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados